Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.

Franzen S, Smith JE, van den Berg E, Rivera Mindt M, van Bruchem-Visser RL, Abner EL, Schneider LS, Prins ND, Babulal GM, Papma JM

Open source

DOI: 10.1002/alz.12433
Published: 2022 Apr
Container: Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/alz.12433,
  title = {Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.},
  author = {Franzen S and Smith JE and van den Berg E and Rivera Mindt M and van Bruchem-Visser RL and Abner EL and Schneider LS and Prins ND and Babulal GM and Papma JM},
  year = {2022},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.12433},
  url = {https://doi.org/10.1002/alz.12433}
}

RIS

TY  - JOUR
TI  - Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.
AU  - Franzen S
AU  - Smith JE
AU  - van den Berg E
AU  - Rivera Mindt M
AU  - van Bruchem-Visser RL
AU  - Abner EL
AU  - Schneider LS
AU  - Prins ND
AU  - Babulal GM
AU  - Papma JM
PY  - 2022
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.12433
UR  - https://doi.org/10.1002/alz.12433
ER  -

APA

S, F., JE, S., E, V. D. B., M, R. M., RL, V. B., EL, A., LS, S., ND, P., GM, B., & JM, P. (2022). Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.12433

Source records

pubmed · retrieved 2026-09-26T11:13:43.346Z